GlassScriptPhysician profile
Jennifer M Moss
NPI 1740662071
$1,704.56
in general payments reported to CMS, 2019-2025
17 companies · $477 in 2025
The $477 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $51.31 · 2022: $296 · 2023: $230 · 2024: $650 · 2025: $477.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,358.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,357.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $295.52 | 2022 | |
| Revance Therapeutics, INC. | $251.96 | 2024 | Daxxify, Daxi |
| Boston Scientific Corporation | $200.50 | 2023-2024 | Watchman Flx |
| Abbvie INC. | $169.73 | 2021-2025 | |
| Merz North America, INC. | $141.28 | 2024 | |
| Edwards Lifesciences Corporation | $136.88 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Janssen Biotech, INC. | $119.21 | 2024-2025 | Tremfya |
| Cvrx, INC. | $107.50 | 2025 | Barostim Neo System |
| Genzyme Corporation | $99.70 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $43.59 | 2024-2025 | Entyvio |
| Janssen Pharmaceuticals, INC | $32.21 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $22.24 | 2024 | Dupixent |
| Novartis Pharmaceuticals Corporation | $20.63 | 2025 | |
| Sumitomo Pharma America, INC. | $20.30 | 2025 | Gemtesa |
| Amgen INC. | $15.12 | 2024 | Repatha |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $14.15 | 2023 | Kcentra |
| Kestra Medical Technology Services, INC. | $14.04 | 2024 | Assure Wcd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Moss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.